‘Egg timer’ tests can’t reliably predict chance of conceiving or menopause timing

Prof Jenny Doust

writer

Prof Jenny Doust

Clinical Professorial Research Fellow, The University of Queensland

Dr Karin Hammarberg

writer

Dr Karin Hammarberg

Senior Research Fellow, Global and Women’s Health, School of Public Health & Preventive Medicine, Monash University

Tessa Copp

writer

Tessa Copp

NHMRC Emerging Leader Research Fellow, University of Sydney

Many women who want to have children and are getting older worry about their fertility. The “egg timer” blood test is marketed as an empowering way to give women insights to help them plan when to have children.

Online companies are now also selling the test directly to consumers to do at home, promoting the test as a way for women to decide when to have a baby, even if they aren’t thinking of having one any time soon.

But it can’t reliably predict the likelihood of pregnancy or how long it would take to get pregnant.

Despite this, egg timer testing is promoted to women not undergoing IVF as a way to assess their current and future fertility.

Our analysis of Australian and New Zealand fertility clinic websites found some claimed the test could predict a woman’s chance of conceiving or identify women at risk of early menopause.

What can and can’t the test do?

The test measures the level of anti-Mullerian hormone (AMH) in the blood and is known clinically as an AMH test.

AMH is produced by follicles in the ovaries (little fluid-filled sacs that contain immature eggs) and helps follicles and eggs grow during the menstrual cycle. Because the number of follicles in the ovaries drops with increasing age, the level of AMH also falls.

The AMH level indicates the number of eggs in the ovaries, or ovarian reserve.

It is often used in IVF treatment, as it can suggest how many eggs a woman may get when her ovaries are stimulated with fertility drugs.

But it can’t tell you anything about egg quality. Women with low AMH levels have the same chance of conceiving as women with normal AMH levels.

It also can’t reliably predict menopause timing for individual women.

Because of this, the American College of Obstetricians and Gynaecologists strongly discourages AMH testing in women who are not seeking fertility treatment. It states the test:

should not be ordered or used to counsel women who are not infertile about their reproductive status and future fertility potential.

No similar guidance has been published by the relevant colleges in Australia.

Who gets AMH tests and why?

The test isn’t Medicare-subsidised. Most AMH tests are paid for privately by consumers, costing around A$80-$120. Because of this, data on current test usage is not publicly available.

To find out how many women in Australia are accessing AMH testing and why, we conducted the first investigation into its use in Australia.

We surveyed a representative sample of 1,773 women aged 18 to 55, recruited through the Life in Australia national study.

We asked them if and how they had heard about AMH testing, whether they had ever had an AMH test, their main reason for testing and how they accessed the test.

Woman in jeans sits, cross-legged
We asked Australian women about their use of AMH testing.
Imani Bahati/Unsplash

Our results, published today, show 13% of the women had heard about AMH testing and 7% had had an AMH test.

The majority had the test for medically indicated reasons, such as during infertility investigations (51%), or to find out if a medical condition had affected their fertility (11%). This included having had chemotherapy or radiotherapy, endometriosis, thyroid issues, and others.

Concerningly, one-third reported having had the test for other reasons. This included gaining insights into their fertility or inform their reproductive life planning (30%).

Most women who had an AMH test first heard about it from their GP or fertility specialist, suggesting doctors are currently the main drivers of test uptake.

However this may change with the recent emergence of direct-to-consumer AMH testing in Australia, as online companies increase their marketing.

What are the downsides of having an AMH test?

Getting the test to inform you about your fertility may lead you to make choices based on a false premise.

If you get a normal or high AMH result, it may give a false sense of security about delaying pregnancy, when age is the most important factor of female fertility.

If you receive a low result, it may cause unwarranted anxiety about not being able to conceive. This may cause pressure to conceive earlier than desired, or create a sense of urgency and haste towards fertility treatment, such as egg freezing.

Woman sits on her longeroom floor, looking at her laptop
Women need good evidence about the limitations of AMH testing.
Unsplash/Thought Catalog

To make informed decisions about AMH testing, women need clear, evidence-based information. We have developed and are currently testing an evidence-based information guide to assist with this.

Can other tests predict fertility?

Unfortunately, there is no reliable test of a woman’s fertility.

But it’s important to know a woman’s age is the greatest predictor of her chance of pregnancy. The only real way to know your fertility is by trying to get pregnant when you are ready.The Conversation

Tessa Copp, NHMRC Emerging Leader Research Fellow, University of Sydney; Jenny Doust, Clinical Professorial Research Fellow, The University of Queensland, and Karin Hammarberg, Senior Research Fellow, Global and Women’s Health, School of Public Health & Preventive Medicine, Monash University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Nomvuyo Mothobi

Dr Nomvuyo Mothobi

Cervical Cancer Screening Update

Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Non-Pharmacological Management

Prof Finlay Macrae AO

Prof Finlay Macrae AO

Gluten-Free Diet – A Practical Guide

Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Multi-Disciplinary Cardiac Rehabilitation

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Jenny Doust

writer

Prof Jenny Doust

Clinical Professorial Research Fellow, The University of Queensland

Dr Karin Hammarberg

writer

Dr Karin Hammarberg

Senior Research Fellow, Global and Women’s Health, School of Public Health & Preventive Medicine, Monash University

Tessa Copp

writer

Tessa Copp

NHMRC Emerging Leader Research Fellow, University of Sydney

Recent Posts

Latest GP poll

We asked GPs "To what extent do you support or oppose legislation to allow nurse practitioners and endorsed midwives to prescribe PBS medicines and provide Medicare services without an arrangement with a doctor?"

Strongly support

0%

Somewhat support

0%

Neither support nor oppose

0%

Somewhat oppose

0%

Strongly oppose

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

You have completed the Educational Activities component of this resource. 

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.